Effects of Aqueous Sample Content and Aqueous Co-Solvent Composition on UPC 2 Separation Performance

Similar documents
UPC 2 Strategy for Scaling from Analytical to Preparative SFC Separations

Prep 150 LC System: Considerations for Analytical to Preparative Scaling

Basic Principles for Purification Using Supercritical Fluid Chromatography

Routine MS Detection for USP Chromatographic Methods

Multi-Channel SFC System for Fast Chiral Method Development and Optimization

USP Method Transfer and Routine Use Analysis of Irbesartan Tablets from HPLC to UPLC

A Rapid Approach to the Confirmation of Drug Metabolites in Preclinical and Clinical Bioanalysis Studies

Streamlining the Analysis of Oral Contraceptives Using the ACQUITY UPLC H-Class System

A Workflow Approach for the Identification and Structural Elucidation of Impurities of Quetiapine Hemifumarate Drug Substance

Analysis of Organic Light Emitting Diode Materials by UltraPerformance Convergence Chromatography Coupled with Mass Spectrometry (UPC 2 /MS)

The Use of the ACQUITY QDa Detector for a Selective, Sensitive, and Robust Quantitative Method for a Potential Genotoxic Impurity

Enantiomeric and Diastereomeric Separations of Pyrethroids Using UPC 2

Peptide Isolation Using the Prep 150 LC System

Rapid, Reliable Metabolite Ratio Evaluation for MIST Assessments in Drug Discovery and Preclinical Studies

Online Reaction Monitoring of In-Process Manufacturing Samples by UPLC

VALIDATION OF A UPLC METHOD FOR A BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE TOPICAL SOLUTION

LC Technical Information

A Quality by Design (QbD) Based Method Development for the Determination of Impurities in a Peroxide Degraded Sample of Ziprasidone

Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain Waters Corporation, Milford, MA USA APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS

Luna 2.5 µm C18(2)-HST. Advantages of 2.5 µm for increasing the speed of analysis while maintaining high efficiency

Assay Transfer from HPLC to UPLC for Higher Analysis Throughput

Expediting Achiral SFC Method Development Using a Multi-Channel SFC System with MS Detection

penta-hilic UHPLC COLUMNS

Simplified Approaches to Impurity Identification using Accurate Mass UPLC/MS

C18 Column. Care & Use Sheet

Evaluation of Ketone Containing Terpene Compounds using Evaporative Light Scattering Detection

UPC 2 Method Development for Achiral Impurity Analysis

Dilution(*) Chromatography

Analysis of Serum 17-Hydroxyprogesterone, Androstenedione, and Cortisol by UPLC-MS/MS for Clinical Research

Yun W. Alelyunas, Mark D. Wrona, Russell J. Mortishire-Smith, Nick Tomczyk, and Paul D. Rainville Waters Corporation, Milford, MA, USA INTRODUCTION

DEMONSTRATING SUPERIOR LINEARITY: THE ACQUITY UPLC PHOTODIODE ARRAY DETECTOR

Quantitation of High Resolution MS Data Using UNIFI: Acquiring and Processing Full Scan or Tof-MRM (Targeted HRMS) Datasets for Quantitative Assays

ultimate efficiency unleashed [ Cortecs 1.6 µm columns ]

Hydrophilic Interaction Liquid Chromatography: Some Aspects of Solvent and Column Selectivity

APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEY WORDS. Simultaneous high-throughput screening of melamine (MEL) and cyanuric acid (CYA).

Identification and Characterization of an Isolated Impurity Fraction: Analysis of an Unknown Degradant Found in Quetiapine Fumarate

Determination of Beta-Blockers in Urine Using Supercritical Fluid Chromatography and Mass Spectrometry

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

penta-hilic UHPLC COLUMNS

SEAMLESS INTEGRATION OF MASS DETECTION INTO THE UV CHROMATOGRAPHIC WORKFLOW

HPLC Praktikum Skript

Application Note. Authors. Abstract. Pharmaceuticals

Implementation of Methods Translation between Liquid Chromatography Instrumentation

UPLC Method Development and Validation

OVERVIEW INTRODUCTION. Michael O Leary, Jennifer Gough, Tanya Tollifson Waters Corporation, Milford, MA USA

Chiral Separation Using SFC and HPLC

Application Note Pharmaceutical QA/QC. Agilent Application Solution. Authors. Abstract. Syed Salman Lateef Agilent Technologies, Inc.

Solvent Flexibility for Size-Based Polymer Analysis Using the Advanced Polymer Chromatography (APC) System

Supercritical Fluid Chromatography

Quantitative Analysis of EtG and EtS in Urine Using FASt ETG and LC-MS/MS

Quantitative Analysis of EtG and EtS in Urine Using FASt ETG and LC-MS/MS

Shodex TM ODP2 HP series columns

Improved Extraction of THC and its Metabolites from Oral Fluid Using Oasis PRiME HLB Solid Phase Extraction (SPE) and a UPLC CORTECS C 18

Definitive EtG/EtS LC-MS/MS Analysis:

for Acclaim Mixed-Mode HILIC-1 Column

[application note] ACQUITY UPLC/SQD ANALYSIS OF POLYMER ADDITIVES. Peter J. Lee, and Alice J. Di Gioia, Waters Corporation, Milford, MA, U.S.A.

Quantitative analysis of small molecules in biological samples. Jeevan Prasain, Ph.D. Department of Pharmacology & Toxicology, UAB.

C HA R AC T E RIZ AT IO N O F INK J E T P RINT E R C A RT RIDG E INK S USING A CHEMOMETRIC APPROACH

Welcome to our E-Seminar: Choosing HPLC Columns for Faster Analysis Smaller and Faster

Using High Speed/High Resolution Size Exclusion Chromatography Separation of Polymeric Materials with Light Scattering Detection

viridis Columns Bringing a New Dimension to SFC Combining state-of-the-art media manufacturing with industry leading column technology, Viridis

Chromatography and other Separation Methods

Electron Transfer Dissociation of N-linked Glycopeptides from a Recombinant mab Using SYNAPT G2-S HDMS

Appendix II- Bioanalytical Method Development and Validation

Automating Method Development with an HPLC System Optimized for Scouting of Columns and Eluents

Nexera UC Unified Chromatography

ACQUITY UPLC Peptide BEH C 18, 130Å and 300Å Columns

CHAPTER 1 Role of Bioanalytical Methods in Drug Discovery and Development

and water enriched layer at the stationary phase particle-eluent interface [9,11].

[ a ppl ic at ion no t e ]

Reversed Phase Solvents

Trefoil Columns [ CARE AND USE MANUAL ] CONTENTS I. INTRODUCTION I. INTRODUCTION GETTING STARTED III. COLUMN USE IV.

Application Note. Author. Abstract. Xinlei Yang Agilent Technologies Co. Ltd Shanghai, China

CHEM 429 / 529 Chemical Separation Techniques

Biochemistry. Biochemical Techniques HPLC

ANALYSIS OF BASIC COMPOUNDS

Introduction to Pharmaceutical Chemical Analysis

Method Development in Solid Phase Extraction using Non-Polar ISOLUTE SPE Columns for the Extraction of Aqueous Samples

The Secrets of Rapid HPLC Method Development. Choosing Columns for Rapid Method Development and Short Analysis Times

Maximizing Triple Quadrupole Mass Spectrometry Productivity with the Agilent StreamSelect LC/MS System

637. Thiamethoxam. HPLC method

Fast methods for the determination of ibuprofen in drug products

A Case of Pesticide Poisoning: The Use of a Broad-Scope Tof Screening Approach in Wildlife Protection

Rapid Screening and Analysis of Components in Nonalcoholic Drinks Application

Open Column Chromatography, GC, TLC, and HPLC

Determination of 15 phthalate esters by ultra performance convergence chromatography

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Yuhui Yang, An Trinh, Michael Ye, and Tom Henderson 595 North Harrison Road, Bellefonte, PA T HKB

Analysis of Stachydrine in Leonurus japonicus Using an Agilent ZORBAX RRHD HILIC Plus Column with LC/ELSD and LC/MS/MS

CHROMATOGRAPHIC SEPARATION TECHNIQUES SUPERCRITICAL FLUID CHROMATOGRAPHY

Packings for HPLC. Packings for HPLC

Acclaim Mixed-Mode WCX-1

PosterREPRINT COMPARISON OF PEAK PARKING VERSUS AUTOMATED FRACTION ANALYSIS OF A COMPLEX PROTEIN MIXTURE. Introduction

Chemistry 3200 High Performance Liquid Chromatography: Quantitative Determination of Headache Tablets

Automated Sample Preparation of Headspace Standards Using the Agilent 7696 WorkBench

ChromegaChiral TM CSP Media and Columns

PosterREPRINT AN INTERACTIVE PHYSICOCHEMICAL PROPERTY PROFILING SOFTWARE FOR EARLY CANDIDATE ANALYSIS IN DRUG DISCOVERY INTRODUCTION

Automatization for development of HPLC methods

Journal of Pharmaceutical and Biomedical Analysis Letters. Analysis Letters

The Effect of Contact Angle and Wetting on Performance in Solid Phase Extraction

Transcription:

Effects of Aqueous Sample Content and Aqueous Co-Solvent Composition on UPC 2 Separation Performance Christopher Knappy, 1 Norman W Smith, 1 Arundhuti Sen, 1 Paul D Rainville, 2 and Robert S Plumb 2 1 King s College, London, UK; 2 Waters Corporation, Milford, MA, USA APPLICATION BENEFITS Analysis of polar metabolites Throughput Aqueous sample compatibility Resolution UltraPerformance Convergence Chromatography (UPC 2 ) can be used for the direct analysis of polar metabolites from aqueous biological samples, such as urine, or from extracted serum samples. Analytical methods can be rapidly developed from a simple set of starting conditions of column flow-rate, temperature, and pressure. Modifying the co-solvent by the addition of small amounts of water buffer and acid provides rapid high resolution analysis with rapid re-equilibration times. INTRODUCTION Liquid chromatography (LC) coupled with accurate mass, mass-spectrometry has become the technique of choice for the screening of biological fluid such as urine and plasma for small molecule biomarkers. While reversed-phase LC can successfully analyze moderately polar analyst, lipids, and non-polar steroidal metabolites, the analysis of highly polar analytes still represents a challenge. The ability to analyze these biological samples with minimal pre-treatment is critical as the introduction of multiple sample preparation steps can result in a reduction in analytical precision and/or loss of analyte species due to poor solvent solubility. Hydrophilic interaction liquid chromatography (HILIC) has shown some success for the analysis of highly polar compounds, however the long re-equilibration times and low tolerance to highly aqueous sample loading limits its utility. Here we explore the application of UPC 2 for the analysis of polar analytes in aqueous matrices. WATERS SOLUTIONS ACQUITY UPC 2 System ACQUITY UPC 2 Trefoil and Torus Columns KEY WORDS Polar analytes, metabolites, aqueous samples, mass spectrometry 1

E X P E R IM E N TA L Sample description Caffeine was employed as a model polar compound in order to investigate the choice of injection parameters for the analysis of polar compounds by UPC, 2 as it maintains a constant charge across a wide ph range (pka = 14.2) and is both PDA and ES+ active. A standard solution was prepared at a concentration of 0.1 mg/ml -1 in 9:1 heptane:isopropanol. To investigate the feasibility of aqueous sample injection using UPC, 2 0.1 mg/ml -1 solutions of caffeine were prepared using water, methanol (MeOH), ethanol (EtOH), isopropanol (IPA), acetonitrile (ACN), acetone (Me 2 CO), and 9:1 heptane:ipa as solvents. Water miscible organic solvents were chosen in order to appraise their potential as diluents for aqueous solutions during the same set of experiments. Each working solution was analyzed on the ACQUITY UPC 2 System with PDA Detector, with injection volumes ranging from 1 7 μl. The chromatography was performed on an ACQUITY UPC 2 System, comprising of an ACQUITY UPC 2 Binary Solvent Manager, ACQUITY UPC 2 Sample Manager, Automatic Back-Pressure Regulator (ABPR), and an ACQUITY Photo Diode Array (PDA) Detector. The separation was performed on ACQUITY UPC 2 BEH Column (1.7 µm, 3.0 x 100 mm) and eluted with an isocratic mobile phase comprising of 95:5 (v/v) CO 2 :MeOH, operated at 2.5 ml/min. -1 The density of the subcritical fluid was regulated via a column temperature of 55 C and automatic backpressure regulator (ABPR) pressure setting of 2,000 psi. The column effluent was monitored by PDA at 273 nm. LC conditions LC system: ACQUITY UPC 2 Detection: UV 273 nm Column: ACQUITY UPC 2 BEH Column (1.7 µm, 3.0 x 100 mm) Column temp.: 55 C Sample temp.: Room temperature Injection volume: 1 µl/min RESULTS AND DISCUSSION The ACQUITY UPC 2 System produced a highly efficient peak with a mean N value of 18,910 +/- 193 being recorded. An example chromatogram is given in Figure 1. This illustrates that both the ACQUITY UPC 2 System and chromatography column were performing correctly. Figure 1. ACQUITY UPC 2 System with PDA Detector chromatogram (273 nm) of caffeine via the precision test method. Effect of injection solvent on UPC 2 efficiency Very few studies have managed to successfully introduce analytes for SFC as solutions in water without severe disruption to chromatographic peak shapes. 1-3 The effect of different injection solvents was investigated over the injection range of 1-7µL. The polarity ranged from the very polar water and methanol through to the aprotic solvent acetone to the very non-polar heptane/ipa mix. The effect of the injection solvent was evaluated by comparing the efficiency of the observed peak to that of the 9:1 heptane:isopropanol injection solvent and expressed as N rel, where a value >1 represents an improvement in performance and a value <1 represents a reduction in chromatographic performance. The data obtained is presented below in Figure 2. Flow rate: 2.5 ml/min -1 Mobile phase A: CO 2 Mobile phase B: Methanol isocratic mobile phase comprising of 95:5 (v/v) CO 2 :MeOH Figure 2. Relative UPC 2 efficiencies for caffeine in various solvents as a function of injection volume. 2

Heptane:IPA gave the smallest changes in N rel with changing injection volume (1.06-0.98), and this is due to the close similarity in polarity to the effluent mobile phase. The water miscible organic solvents gave the poorest efficiencies, progressively deteriorating as solvent polarity increased (i.e. in general, N rel ACN > Me 2 CO > IPA > EtOH > MeOH). The sequence presumably reflects the increasingly poor mismatch in polarity to the eluent. The organic solvents generally showed an anticipated steady decrease in N rel from 1 to 7μL injection as a result of the increasing size of the injection plug. Of the water miscible solvents, acetonitrile and acetone showed the smallest changes in N rel (1.02 0.67 and 0.91 0.58, respectively), and methanol the greatest change (0.70 0.04). Water behaved somewhat unexpectedly as an injection solvent. The maximum efficiency (N rel = 2.05) was significantly higher than for heptane:ipa, despite the poorer mismatch in polarity to the eluent. This maximum efficiency occurred at 2 μl as opposed to 1 μl injection volume, which was the observed optimal injection volume for all of the other pure solvents. The efficiency N rel quickly reduced with injection volumes greater than 2 μl, with peak splitting observed in aqueous injection volumes of 5 μl or greater. Interestingly the use of an acetonitrile:water as the injection solvent sowed and increase in N rel increased up to nearly 6 µl. Although the use of stronger elution injection solvents resulted in marginally earlier elution than heptane:ipa, reductions in retention times were less than 10%. Accordingly, injection in water was not only tolerated in UPC, 2 but effected a reduction in peak broadening at some injection volumes. Of the water miscible organic solvents, acetonitrile showed greatest promise as a potential diluent for aqueous solutions. Several factors could account for the beneficial effect of water on the UPC 2 efficiency for the analysis of caffeine, including improved mass transfer with the polar BEH phase or focusing (reduced longitudinal diffusion) of the elution band. To better assess the influence of water on the chromatographic system as a whole, further investigations were made via modification of both the injection solvent and the co-solvent with water. Further investigation of the effect of water on UPC 2 efficiency To assess the chromatographic benefits of water as an injection solvent irrespective of how it was introduced into the ACQUITY UPC 2 System, a 0.1 mg/ml -1 caffeine solution in the various solvents was analyzed by the ACQUITY UPC 2 System with PDA Detector, using a modification to the method in which 95:5 MeOH:H 2 O was used as the co-solvent instead of pure methanol. The derived data is shown below in Figure 3. The results show that for injection volumes of less than 2 µl, the observed efficiencies for water injections were higher than those obtained for all of the organic injection solvents. Figure 3. Relative UPC 2 efficiencies for caffeine in various solvents as a function of injection volume, achieved using 95:5 MeOH:H 2 O as co-solvent. Interestingly, acetonitrile replaced heptane:ipa as the most tolerant injection solvent, giving the smallest changes in N rel with increasing injection volume (1.37 1.27). Injection in water still yielded the optimal efficiencies, although with smaller magnitudes (maximum N rel =1.72), but these were shifted towards lower injection volumes compared to the non-water containing co-solvent data. The results suggest that water is inherently beneficial to the chromatographic analysis of caffeine whether introduced via the co-solvent or injection solvent. 3

Effect of the proportion and volume of water injected on UPC 2 performance The reduction in UPC 2 efficiency observed in this study at higher aqueous injection volumes suggests a limit to the amount of water that can be injected without deleteriously affecting the chromatography. To determine the dependence of chromatographic performance on the volumetric injection of aqueous solutions, a 0.1 mg/ml -1 solution of caffeine was prepared in 1:1 acetonitrile:water and analyzed using an ACQUITY UPC 2 System with PDA Detector, either with MeOH or 95:5 MeOH:H 2 O as co-solvents. In each case, the maximum efficiency was similar to that obtained via injection of pure water but occurred at approximately double the injection volume, suggesting the volume of the aqueous component was the critical factor, not the total injection volume. In order to identify the maximum amount of water tolerated by UPC, 2 caffeine solutions comprising 0, 10, 33, 50, 67, 90, and 100% water were made by diluting a 1 mg/ml -1 aqueous caffeine stock with acetonitrile to give a total volume of 1 ml. Each solution was then analyzed by using an ACQUITY UPC 2 System with PDA Detecor, using methanol or 95:5 methanol : water as the co-solvent, with the injection volume varied from 1 7 μl. Plots of N rel against the volume of water injected are given in Figure 4. The data shows that a maximum in chromatographic performance occurs when the injection volume contains approximately 2 μl of water. It can be seen that injections with greater volumes of water produced significantly poorer efficiencies irrespective of the co-solvents. By contrast, injection of lesser volumes of water were highly detrimental to the chromatographic efficiency in MeOH co-solvent, but only moderately detrimental with the MeOH:H 2 O (95:5) co-solvent. The results suggest that the total volume of water injected should be kept 2 μl for UPC, 2 irrespective of the composition of the injection solvent. Effect of system parameters on UPC 2 efficiency Along with the injection conditions, changes to the ACQUITY UPC 2 System operating parameters could also enhance, diminish or destroy the beneficial effects of water on the chromatographic performance of UPC 2 for polar analytes. To determine the optimal operating parameters and robustness to changes in these conditions the proportion of co-solvent in the eluent (2 10% methanol), the eluent flow rate (1.0 3.0 ml/min -1 ), the ABPR pressure (1,500 3,000 psi), and the column temperature (35 75 C) were independently varied in order to screen for any influences on system efficiency (N rel ). For these experiments, 1:1 acetronitrile:water was employed as the injection solvent and a 5 μl injection volume was chosen as previous data suggested that these conditions gave optimal or near-optimal efficiencies with either MeOH or MeOH:H 2 O co-solvents. A 5 μl injection of caffeine in 9:1 heptane:ipa was employed to determine N rel. Figure 4. Relative UPC 2 efficiencies for caffeine in pure H 2 O and in ACN:H 2 O solutions, plotted as a function of the total volume of water injected, with a) methanol and b) 95:5 MeOH:H 2 O as co-solvent. Figure 5. Relative UPC 2 efficiencies for caffeine in aqueous (n) and control ( ) solutions, achieved via modifications to a) % MeOH co-solvent compositon, b) eluent flow rate, c) ABPR pressure, and d) column temperature. 4

From a careful interrogation of the data shown in Figure 5 it can be determined that the parameters which gave optimal efficiencies were largely the same for both aqueous and control solutions, with the notable exception of those for column temperature, which optimized at 55 C and 35 C, respectively. For both injection solvents, N rel values increased with increasing ABPR pressure up to 3000 psi. For each of the system parameters, N rel was far more sensitive to systematic change when the aqueous injection solvent was employed rather than heptane:ipa (9:1) This data suggest that particular care should be taken to optimize the parameters when using aqueous solutions, as small changes can severely diminish the chromatographic efficiency. CONCLUSIONS UPC 2 can be employed for the analysis of polar analytes in aqueous media if the injection volume and co-solvent conditions are carefully controlled Enhanced UPC 2 efficiency was observed when water was incorporated in the co-solvent at low concentrations. The UPC 2 chromatographic efficiency of polar analytes increased linearly with pressure, and increased with temperature up to 50 C, a flow-ratepressure combination of 2 ml/min and 3,000 psi yielded a good starting point for method development. References 1. Gyllenhaal O. Packed column supercritical fluid chromatography of a peroxisome proliferator-activating receptor agonist drug: Achiral and chiral purity of substance, formulation assay and its enantiomeric purity. J Chrom A. 2004;1042:173 80. 2. Mukherjee PS and Cook SE. A feasibility study on direct assay of an aqueous formulation by chiral supercritical fluid chromatography (SFC). J Pharm Biomed Anal. 2006;41:1287 92. 3. Mukherjee PS. Validation of direct assay of an aqueous formulation of a drug compound AZY by chiral supercritical fluid chromatography (SFC). J Pharm Biomed Anal. 2007;43:464 70. 4. Liu Y, Li X, Yang C, Tai S, Zhang X, Liu G. UPLC/MS-MS Method for Simultaneous Determination of caffeine, Tolbutamide, Metoprolol, and Dapsone in Rat Plasma and its Application to Cytochrome P450 Activity Study in Rats. J Chrom Sci. 2013;51:26 32. 5. Taylor LT. Packed column supercritical fluid chromatography of hydrophilic analytes via water-rich modifiers. J Pharm Biomed Anal. 2012;43:464 70. Waters, The Science of What s Possible, UPC, 2 and ACQUITY UPC 2 are registered trademarks of Waters Corporation. UltraPerformance Convergence Chromatography, Trefoil, and Torus are trademarks of Waters Corporation. All other trademarks are the property of their respective owners. 2015 Waters Corporation. Produced in the U.S.A. September 2015 720005505EN AG-PDF Waters Corporation 34 Maple Street Milford, MA 01757 U.S.A. T: 1 508 478 2000 F: 1 508 872 1990 www.waters.com